#cemark

Medical devices and In Vitro Diagnostic Devices (IVDs) intended for the European market must comply with strict regulatory requirements under the European Medical Device Regulation (EU MDR 2017/745) and In Vitro Diagnostic Regulation (EU IVDR 2017/746). CE marking demonstrates that a product meets the applicable safety, performance, and regulatory requirements necessary for commercialization within the European Union.

Manufacturers often require regulatory guidance to understand applicable requirements, prepare technical documentation, coordinate with notified bodies, and complete conformity assessment procedures successfully.

What Is CE Certification for Medical Devices?

CE certification is a regulatory conformity process that confirms a medical device or IVD complies with European regulatory requirements. Depending on the classification and intended purpose of the device, manufacturers may need involvement from a notified body before placing the product on the European market.

The CE marking process generally includes:

Device classification

Identification of applicable standards

Preparation of technical documentation

Risk management documentation

Clinical or performance evaluation

Post market surveillance documentation

Declaration of conformity

Notified body assessment, where applicable

Technical Documentation Requirements Under EU MDR and IVDR

Under Annex II and Annex III of EU MDR and IVDR, manufacturers are required to maintain detailed technical documentation demonstrating product safety and performance.

Technical documentation may include:

General Safety and Performance Requirements (GSPR)

Risk management files

Clinical evaluation reports

Performance evaluation documentation

Usability engineering documentation

Software validation documentation

Biological evaluation

Labeling and IFU review

Verification and validation reports

Post Market Surveillance (PMS) documentation

The documentation requirements vary depending on the device classification, intended purpose, and applicable conformity assessment route.

CE Certification for Software as a Medical Device (SaMD)

Software intended for medical purposes may qualify as Software as a Medical Device (SaMD) under EU MDR 2017/745. Manufacturers developing medical software applications must ensure compliance with applicable regulatory and software lifecycle requirements before obtaining CE marking.

Regulatory activities for SaMD may include:

Software classification

Cybersecurity considerations

Software lifecycle documentation

Clinical evaluation

Usability engineering

Risk management

Validation and verification activities

Compliance with standards such as IEC 62304, IEC 82304-1, IEC 62366, and ISO 14971 is commonly required during the conformity assessment process.

Post Market Surveillance (PMS) Requirements

EU MDR and IVDR require manufacturers to establish a systematic Post Market Surveillance (PMS) process to continuously monitor product safety and performance after market placement.

PMS documentation may include:

PMS Plan

PMS Report

Periodic Safety Update Report (PSUR)

Post Market Clinical Follow-up (PMCF) documentation for medical devices

Post Market Performance Follow-up (PMPF) documentation for IVDs

The scope and frequency of PMS activities depend on the device classification and associated risks.

Clinical Evaluation for Medical Devices

Clinical evaluation is a mandatory requirement under EU MDR and is used to demonstrate the safety and clinical performance of a medical device.

Clinical evaluation activities generally involve:

Clinical Evaluation Plan (CEP)

Literature search protocol

Literature review and appraisal

Clinical Evaluation Report (CER)

Assessment of clinical data and equivalence

Manufacturers must ensure that the clinical evidence adequately supports the intended purpose and claims associated with the device.

Performance Evaluation for In Vitro Diagnostic Devices

Under EU IVDR, IVD manufacturers are required to conduct performance evaluations demonstrating scientific validity, analytical performance, and clinical performance.

Performance evaluation documentation may include:

Performance Evaluation Plan (PEP)

Scientific validity reports

Analytical performance reports

Clinical performance reports

Performance Evaluation Report (PER)

These documents form an important part of the technical documentation reviewed during conformity assessment.

Role of the European Authorized Representative (EAR)

Manufacturers located outside the European Union are required to appoint a European Authorized Representative (EAR) when placing products on the EU market.

The EAR acts as the manufacturer’s authorized regulatory representative within Europe and supports communication with competent authorities and notified bodies in accordance with EU MDR and EU IVDR requirements.

Importance of Regulatory and Technical Documentation Support

Preparing EU MDR and IVDR documentation requires understanding of evolving regulations, harmonized standards, guidance documents, and notified body expectations.

Regulatory support may help manufacturers with:

Identification of applicable regulatory pathways

Technical documentation preparation

Gap assessment

Compliance strategy

Audit preparation

Resolution of notified body observations

Ongoing regulatory maintenance activities

Proper documentation planning and regulatory coordination can help streamline the conformity assessment process and reduce delays during certification activities.

Key Considerations Before Starting CE Marking

Manufacturers planning CE certification should consider:

Device classification accuracy

Applicable harmonized standards

Clinical or performance evidence requirements

PMS obligations

Software validation requirements

Notified body availability and timelines

Regulatory updates under EU MDR and IVDR

Clinical Evaluation is one of the most important requirements for medical devices under EU MDR 2017/745. It is a systematic and ongoing process used to collect, assess, and analyze clinical data to demonstrate that a medical device is safe, performs as intended, and provides clinical benefits to patients.

Under the European Medical Device Regulation (EU MDR), manufacturers must provide strong clinical evidence to support compliance with the General Safety and Performance Requirements (GSPR). Clinical evaluation applies to all classes of medical devices and must be continuously updated throughout the product lifecycle.

What is Clinical Evaluation?

Clinical Evaluation is a documented assessment of clinical data related to a medical device. The purpose is to confirm:

Device safety and performance

Clinical benefits for intended users

Acceptable benefit-risk profile

Compliance with EU MDR requirements

The evaluation considers factors such as device design, intended purpose, medical indications, risks, side effects, duration of use, and current state of the art in the medical field.

A well-prepared clinical evaluation demonstrates that the device achieves its intended medical purpose without exposing patients or users to unnecessary risks.

Why Clinical Evaluation is Important Under EU MDR?

EU MDR 2017/745 places greater emphasis on clinical evidence compared to previous directives. Manufacturers must now provide more robust and scientifically valid documentation to obtain CE marking.

Clinical evaluation helps manufacturers:

Demonstrate compliance with GSPR requirements

Establish clinical safety and effectiveness

Support CE marking submissions

Identify and assess clinical risks

Monitor ongoing device performance

Maintain regulatory compliance during audits

Without proper clinical evaluation documentation, obtaining CE certification becomes difficult.

Key Components of Clinical Evaluation

Clinical Evaluation Plan (CEP)

A Clinical Evaluation Plan outlines the strategy and methodology for conducting the clinical evaluation process.

The CEP typically includes:

Scope and objectives

Device description

Intended purpose

Clinical claims

Data sources

Literature search methods

Evaluation criteria

Risk-benefit assessment approach

The plan ensures that the evaluation process remains structured, transparent, and compliant with MDR expectations.

Clinical Evaluation Report (CER)

The Clinical Evaluation Report is the final documented outcome of the clinical evaluation process.

A CER includes:

Clinical data analysis

Safety and performance assessment

Literature review findings

Benefit-risk evaluation

Clinical conclusions

Post-market surveillance considerations

The report demonstrates that sufficient clinical evidence exists to support the device’s safety and intended performance.

A strong CER is essential for technical documentation and notified body review under EU MDR.

Demonstration of Equivalence

Manufacturers may use clinical data from an equivalent medical device to support their own device evaluation.

To demonstrate equivalence, manufacturers must compare:

Technical characteristics

Biological characteristics

Clinical characteristics

This approach can reduce the need for additional clinical investigations while still supporting regulatory compliance.

However, MDR has introduced stricter requirements for equivalence justification, making proper documentation critical.

Literature Search Protocol and Report

A literature search is an important part of clinical evaluation.

Literature Search Protocol

Defines:

Search strategy

Databases used

Keywords and inclusion criteria

Scientific appraisal methods

Literature Search Report

Summarizes:

Relevant scientific literature

Clinical evidence identified

Safety and performance findings

Evaluator conclusions

A systematic literature review helps support clinical claims using published scientific evidence.

Clinical Evaluation and Technical Documentation

Clinical evaluation forms a major part of MDR technical documentation.

Manufacturers must provide evidence showing:

Compliance with General Safety and Performance Requirements (GSPR)

Acceptability of benefit-risk ratio

Identification of undesirable side effects

Adequate clinical evidence for conformity assessment

The documentation must remain updated throughout the device lifecycle using post-market surveillance data and ongoing clinical evaluation activities.

Clinical Evaluation Report Writing Services

Professional CER writing services help manufacturers prepare compliant and audit-ready documentation under EU MDR 2017/745.

Experienced CER writers:

Analyze scientific literature

Evaluate clinical evidence

Assess safety and performance

Prepare structured MDR-compliant reports

Support notified body submissions

A well-written Clinical Evaluation Report improves regulatory confidence and helps streamline CE marking approval.

Conclusion

Clinical Evaluation is a critical regulatory requirement under EU MDR 2017/745. It provides scientific evidence that a medical device is safe, effective, and clinically beneficial for its intended use.

From Clinical Evaluation Plans and CER writing to literature reviews and equivalence demonstration, every part of the process contributes to building strong technical documentation and achieving successful CE marking.

The UK MHRA has extended the acceptance of CE-marked medical devices until June 30, 2030 under specific conditions. In our latest blog, Sushvin Consultancy breaks down what this means for manufacturers and how we can help ensure seamless regulatory compliance during the transition to UKCA marking.

💡 Learn how to stay compliant, manage certification changes, and prepare your technical documentation. 📌 Explore action steps, deadlines, and our expert guidance.

📖 Read now: https://www.sushvin.com/uk-ce-mark-extension-medical-device-compliance.html